RARECast

548 Episodo

1. Crowdsourcing Therapeutic Approaches for an Ultra-Rare Disease

   Publicado: 5/2/2020
2. Delivering Oligonucleotide Therapies to Any Cell Type

   Publicado: 29/1/2020
3. Protalix Looks Beyond Biobetters

   Publicado: 22/1/2020
4. Driving N-of-1 Therapies for Ultra-Rare Disease Patients

   Publicado: 15/1/2020
5. Cutting the Time and Cost of Drug Discovery with MicroOrgans

   Publicado: 8/1/2020
6. Acquisition Combines Two Pipelines for Rare Skin Diseases

   Publicado: 2/1/2020
7. Programming Cells to Produce Neuroprotective Factors to Treat ALS

   Publicado: 26/12/2019
8. Origin's Rapid Path to Seek Approval for Treatment of Ultra-Rare Metabolic Condition

   Publicado: 18/12/2019
9. Developing a Common Language for Rare Diseases

   Publicado: 11/12/2019
10. Why Payers Lag Drug Developers and Regulators in Embracing Real-World Evidence

    Publicado: 4/12/2019
11. How a Brother's Love Is Forging a Path for Customized Therapies for Rare Disease Patients

    Publicado: 27/11/2019
12. Addressing the Barriers to Accessing Experimental Therapies

    Publicado: 20/11/2019
13. A Journey to Advocacy

    Publicado: 13/11/2019
14. Turning Chronic Illness into a Fashion Statement

    Publicado: 6/11/2019
15. Connecting Young Adults with Rare and Chronic Conditions

    Publicado: 30/10/2019
16. Helping Caregivers Care for Themselves

    Publicado: 23/10/2019
17. A Festival of Moving Pictures

    Publicado: 16/10/2019
18. Deep Genomics Boasts an AI First in Drug Discovery

    Publicado: 9/10/2019
19. How to Live with a Disability with Your Mojo Intact

    Publicado: 3/10/2019
20. Why a Big Pharma Exec Embraced Rare Neurological Diseases

    Publicado: 25/9/2019